Immunoglobulin replacement therapy and infection risk in chronic lymphocytic leukemia: A systematic review and meta-analysis

doi:10.12998/wjcc.v14.i9.118210

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 9

This Article

(36)

(39)

(0)

(8)

(778)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Clin Cases. Mar 26, 2026; 14(9): 118210
Published online Mar 26, 2026. doi: 10.12998/wjcc.v14.i9.118210

Full Size Figure Download Figure

Figure 1 Flowchart of the study selection process.

Citation: Kalamara TV, Dodos K, Georgakopoulou VE. Immunoglobulin replacement therapy and infection risk in chronic lymphocytic leukemia: A systematic review and meta-analysis. World J Clin Cases 2026; 14(9): 118210
URL: https://www.wjgnet.com/2307-8960/full/v14/i9/118210.htm
DOI: https://dx.doi.org/10.12998/wjcc.v14.i9.118210

Kalamara TV, Dodos K, Georgakopoulou VE. Immunoglobulin replacement therapy and infection risk in chronic lymphocytic leukemia: A systematic review and meta-analysis. World J Clin Cases 2026; 14(9): 118210 [DOI: 10.12998/wjcc.v14.i9.118210]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.